Argitalpenak (341) MARIO FERNÁNDEZ RUIZ argitalpenak

2024

  1. BK polyomavirus-associated nephropathy, graft inflammation, and immunosuppression: Shedding light on the conundrum

    Transplant Infectious Disease

  2. Bacteremia due to Leuconostoc species: A 13-year single-center case series

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 3, pp. 149-151

  3. Current Challenges and Advances on Infectious Diseases in Solid Organ Transplantation

    Transplant International

  4. Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice

    Antiviral Research, Vol. 227

  5. Donor-Dependent Variations in Systemic Oxidative Stress and Their Association with One-Year Graft Outcomes in Kidney Transplantation

    American journal of nephrology, Vol. 55, Núm. 5, pp. 509-519

  6. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

  7. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease

  8. How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 442-452

  9. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation, Vol. 24, Núm. 7, pp. 1180-1192

  10. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

  11. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

  12. Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients

    Transplant Infectious Disease

  13. Pharmacological management of invasive mold infections in solid organ transplant recipients

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 3, pp. 239-254

  14. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

  15. Prophylactic Anticoagulation Reduces the Risk of Kidney Graft Venous Thrombosis in Recipients from Uncontrolled Donation after Circulatory Death Donors with High Renal Resistive Index

    Transplantation Direct, Vol. 10, Núm. 6, pp. E1649

  16. Recurrent Clostridioides difficile infections in solid organ transplant recipients: The international CALIPSO study

    Journal of Infection, Vol. 89, Núm. 6

  17. Reduction of Instrumentation-Related Spine Surgical Site Infections After Optimization of Surgical Techniques. A Single Center Retrospective Analysis

    Global Spine Journal, Vol. 14, Núm. 2, pp. 438-446

  18. Risk factors for poor outcome in adult patients with respiratory syncytial virus infection evaluated at the emergency department

    Journal of Medical Virology, Vol. 96, Núm. 10

  19. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

    Transplant Infectious Disease, Vol. 26, Núm. 1

  20. Spatial Relationship between a Regional Outbreak and a Higher-than-Expected Incidence of Leishmaniasis in Urban Southern Madrid, Spain

    The American journal of tropical medicine and hygiene, Vol. 111, Núm. 4, pp. 814-818